BiotechTube
Boston Oncology

Boston Oncology

Boston, United States· Est.
bostononcology.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $33M

Overview

Boston Oncology, founded in 2018, is a private biogenerics company with a unique international footprint bridging the US and the Middle East. Its core model involves licensing USFDA/EMA-registered biogenerics and manufacturing them in its GMP-certified facility in Saudi Arabia, which has an annual capacity of over 30 million vials. The company aims to provide affordable, high-quality medicines to underserved markets, aligning with strategic initiatives like Saudi Arabia's Vision 2030. It is positioned as a mission-driven, customer-centered organization leveraging global expertise for local health impact.

Oncology

Technology Platform

Integrated biogenerics platform focused on licensing USFDA/EMA-registered products, transferring specialized manufacturing knowledge, and flexible, modular GMP production in a strategic local facility.

Funding History

2
Total raised:$33M
Series A$25M
Seed$8M

Opportunities

Significant opportunity in providing high-quality, affordable generic medicines to developing markets, particularly in the MENA region.
Strategic alignment with Saudi Arabia's Vision 2030 initiative for pharmaceutical localization offers a favorable regulatory and economic environment for growth and expansion.

Risk Factors

Faces regulatory complexities across multiple jurisdictions, dependence on licensing agreements with innovator pharma companies, and intense price competition in the global generics market.
Operational execution risk in running a new, large-scale international manufacturing facility is also a key challenge.

Competitive Landscape

Competes with large multinational generic drug manufacturers (e.g., Teva, Sandoz) on scale and price, and with local generic producers in target markets. Differentiates through its US-quality focus, strategic manufacturing base in Saudi Arabia, and integrated 'single-point-of-contact' model for procurement and supply.

More companies in United States →